A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis

Michael L. Volk, Jessica Mellinger, Meena B. Bansal, Ziad F. Gellad, Mark McClellan, Fasiha Kanwal

Research output: Contribution to journalArticle

Abstract

Healthcare reimbursement is shifting from fee-for-service to fee-for-value. Cirrhosis, which costs the U.S. healthcare system as much as heart failure, is a prime target for value-based care. This article describes models in which physician groups or health systems are paid for improving quality and lowering costs for a given population of patients with cirrhosis. If done correctly, we believe that such frameworks, once adopted, could help reduce burnout by freeing physicians of the burden of checking boxes in the electronic medical record so that they can devote their energies to managing populations. Conclusion: Value-based payment models for cirrhosis have the potential to benefit patients, physicians, and healthcare insurers.

Original languageEnglish (US)
Pages (from-to)1300-1305
Number of pages6
JournalHepatology
Volume69
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Fibrosis
Delivery of Health Care
Physicians
Costs and Cost Analysis
Fee-for-Service Plans
Insurance Carriers
Fees and Charges
Electronic Health Records
Population
Heart Failure
Health

ASJC Scopus subject areas

  • Hepatology

Cite this

Volk, M. L., Mellinger, J., Bansal, M. B., Gellad, Z. F., McClellan, M., & Kanwal, F. (2019). A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis. Hepatology, 69(3), 1300-1305. https://doi.org/10.1002/hep.30277

A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis. / Volk, Michael L.; Mellinger, Jessica; Bansal, Meena B.; Gellad, Ziad F.; McClellan, Mark; Kanwal, Fasiha.

In: Hepatology, Vol. 69, No. 3, 01.03.2019, p. 1300-1305.

Research output: Contribution to journalArticle

Volk, ML, Mellinger, J, Bansal, MB, Gellad, ZF, McClellan, M & Kanwal, F 2019, 'A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis', Hepatology, vol. 69, no. 3, pp. 1300-1305. https://doi.org/10.1002/hep.30277
Volk ML, Mellinger J, Bansal MB, Gellad ZF, McClellan M, Kanwal F. A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis. Hepatology. 2019 Mar 1;69(3):1300-1305. https://doi.org/10.1002/hep.30277
Volk, Michael L. ; Mellinger, Jessica ; Bansal, Meena B. ; Gellad, Ziad F. ; McClellan, Mark ; Kanwal, Fasiha. / A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis. In: Hepatology. 2019 ; Vol. 69, No. 3. pp. 1300-1305.
@article{209b72eb929f4ba0aaa0e819fcfcdb3c,
title = "A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis",
abstract = "Healthcare reimbursement is shifting from fee-for-service to fee-for-value. Cirrhosis, which costs the U.S. healthcare system as much as heart failure, is a prime target for value-based care. This article describes models in which physician groups or health systems are paid for improving quality and lowering costs for a given population of patients with cirrhosis. If done correctly, we believe that such frameworks, once adopted, could help reduce burnout by freeing physicians of the burden of checking boxes in the electronic medical record so that they can devote their energies to managing populations. Conclusion: Value-based payment models for cirrhosis have the potential to benefit patients, physicians, and healthcare insurers.",
author = "Volk, {Michael L.} and Jessica Mellinger and Bansal, {Meena B.} and Gellad, {Ziad F.} and Mark McClellan and Fasiha Kanwal",
year = "2019",
month = "3",
day = "1",
doi = "10.1002/hep.30277",
language = "English (US)",
volume = "69",
pages = "1300--1305",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - A Roadmap for Value-Based Payment Models Among Patients With Cirrhosis

AU - Volk, Michael L.

AU - Mellinger, Jessica

AU - Bansal, Meena B.

AU - Gellad, Ziad F.

AU - McClellan, Mark

AU - Kanwal, Fasiha

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Healthcare reimbursement is shifting from fee-for-service to fee-for-value. Cirrhosis, which costs the U.S. healthcare system as much as heart failure, is a prime target for value-based care. This article describes models in which physician groups or health systems are paid for improving quality and lowering costs for a given population of patients with cirrhosis. If done correctly, we believe that such frameworks, once adopted, could help reduce burnout by freeing physicians of the burden of checking boxes in the electronic medical record so that they can devote their energies to managing populations. Conclusion: Value-based payment models for cirrhosis have the potential to benefit patients, physicians, and healthcare insurers.

AB - Healthcare reimbursement is shifting from fee-for-service to fee-for-value. Cirrhosis, which costs the U.S. healthcare system as much as heart failure, is a prime target for value-based care. This article describes models in which physician groups or health systems are paid for improving quality and lowering costs for a given population of patients with cirrhosis. If done correctly, we believe that such frameworks, once adopted, could help reduce burnout by freeing physicians of the burden of checking boxes in the electronic medical record so that they can devote their energies to managing populations. Conclusion: Value-based payment models for cirrhosis have the potential to benefit patients, physicians, and healthcare insurers.

UR - http://www.scopus.com/inward/record.url?scp=85061961328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061961328&partnerID=8YFLogxK

U2 - 10.1002/hep.30277

DO - 10.1002/hep.30277

M3 - Article

C2 - 30226642

AN - SCOPUS:85061961328

VL - 69

SP - 1300

EP - 1305

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -